Improved Neuronal Cell Survival in 3D Model of Alzheimer's
Filed with ASX · · 3 pages · English
Invex Therapeutics Ltd. on 6ix
Earlier from Invex Therapeutics
- Quarterly Activities Report and Appendix 4C
- Invex receives R&D Tax Rebate
- ATO Class Ruling Return of Capital
- Appendix 4D and Half year report
- Invex and Peptron Mutually Terminate Manufacturing Agreement
Later from Invex Therapeutics
- Invex Receives $0.22m R&D Tax Rebate from UK Government
- Appendix 4E and Annual Report to shareholders
- Trading Halt
- Suspension from Quotation
- Corporate Update
Follow Invex Therapeutics into a list and get an email when it puts out news.
Follow Invex Therapeutics